Study details
Enrolling now
A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers
Organogenesis
NCT IDNCT06618612ClinicalTrials.gov data as of Apr 2026
Target enrollment
170
Study length
about 2.3 years
Ages
18+
Locations
1 site in OH
What this study is about
Researchers are testing whether a new treatment, PuraPly AM or XT, combined with standard care helps heal non-healing diabetic foot ulcers better than standard care alone. The trial will last for 822 days and involve approximately 170 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Standard of Care
- 2.Use PuraPly AM
- 3.Use PuraPly XT
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: The number of adverse events.